Status:

COMPLETED

Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

ETH Zurich (Switzerland)

Conditions:

Brown Adipose Tissue

Metabolic Disease

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

To test the hypothesis that active BAT improves metabolic health by buffering postprandial metabolites plasma metabolites and energy expenditure will be compared in volunteers with and without active ...

Detailed Description

In this prospective interventional study healthy individuals will be screened for presence of active BAT: Maximal BAT activity will be achieved by a mild cold stimulus over 2 hous and quantified by 18...

Eligibility Criteria

Inclusion

  • BMI 18.5 to 28 kg/m2
  • Able to give informed consent as documented by signature

Exclusion

  • Concomitant medication other than prescription free analgesics (paracetamol and NSAID) and oral contraceptives
  • Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, diabetes mellitus)
  • Hyper- or hypothyroidism
  • Smoker / habitual tobacco use
  • Weight change of \>5% within 3 months prior to inclusion
  • Hypersensitivity to cold (e.g. Raynaud syndrome)
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • Enrolment into another study using ionizing radiation within the previous 12 months
  • Enrolment into another study including a pharmacological or nutritional intervention
  • Pregnancy or lactation
  • Lab parameters
  • Serum-Creatinine: above 1.5x upper limit of normal (ULN)
  • Glycated Hemoglobin (HbA1c): above 6.0%
  • Random plasma glucose \>11 mM

Key Trial Info

Start Date :

October 12 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06078345

Start Date

October 12 2023

End Date

August 15 2025

Last Update

November 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Basel, Dept. of Endocrinology

Basel, Switzerland